Relative performance of brivaracetam as adjunctive treatment of focal seizures in adults: a network meta-analysis-Reference-Cited by-同舟云学术

Relative performance of brivaracetam as adjunctive treatment of focal seizures in adults: a network meta-analysis

Published:2019-03-27 Issue:8 Volume:35 Page:1345-1354
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Charokopou Mata¹,Harvey Rebecca²,Srivastava Kunal³,Brandt Christian⁴,Borghs Simon⁵

Affiliation:

1. UCB Pharma, Brussels, Belgium;

2. BresMed Health Solutions Ltd, Sheffield, UK;

3. BresMed India, Gurugram, Haryana, India;

4. Department of General Epileptology, Bethel Epilepsy Centre, Mara Hospital, Bielefeld, Germany;

5. UCB Pharma, Slough, Berkshire, UK

Funder

UCB Pharma

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2019.1584501

Reference34 articles.

1. The consequences of refractory epilepsy and its treatment

2. Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: Relationship to anti-convulsant properties

3. NICE. Guide to the methods of technology appraisal [Internet]. 2013 [cited 2016 Apr 4]. Available from: https://www.nice.org.uk/article/pmg9/chapter/Foreword.

4. Meta-analyses of antiepileptic drugs for refractory partial (focal) epilepsy: an observation

5. Difficulties in extrapolating from clinical trial data to clinical practice: The case of antiepileptic drugs

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epilepsien;Arzneiverordnungs-Report 2023;2023

2. Epilepsien;Arzneiverordnungs-Report 2022;2022

3. Cost-utility model of brivaracetam in the adjunctive treatment of patients with epilepsy in Spain;Expert Review of Pharmacoeconomics & Outcomes Research;2020-11-06

4. A review of the drug−drug interactions of the antiepileptic drug brivaracetam;Epilepsy Research;2020-07

5. Economic Value of Adjunctive Brivaracetam Treatment Strategy for Focal Onset Seizures in Finland;Advances in Therapy;2019-12-05